{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:40:49Z","timestamp":1793018449120,"version":"4.5.0"},"reference-count":39,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"Regional research commitee of Region Zaeland"},{"name":"NSR Hospital local research committee"},{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","award":["16-R107-A6790-22002"],"award-info":[{"award-number":["16-R107-A6790-22002"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","award":["16-R107-A6819-22002"],"award-info":[{"award-number":["16-R107-A6819-22002"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","award":["18-R125-A8444-22110"],"award-info":[{"award-number":["18-R125-A8444-22110"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Myocardial interstitial fibrosis expands the extracellular volume (ECV) and in patients with type 2 diabetes is implicated in development of heart failure. ECV can be determined with gadolinium contrast MRI. We investigated which known risk factors for cardiovascular disease were associated with increased ECV in patients with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>A total of 296 patients with type 2 diabetes and 25 sex and age-matched control subjects were included in a cross-sectional MRI study. The influence of risk factors on ECV was investigated with multiple regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Control subjects and patients with type 2 diabetes without complications had similar ECV (mean \u00b1 SD 27.4 \u00b1 2.1% vs. 27.9 \u00b1 2.6%, P = 0.4). Compared with patients without, ECV was significantly increased in patients with one or more complications (29.0 \u00b1 3.3%, P = 0.02). Both in univariable analysis and after multivariable adjustment, ischemic heart disease, autonomic neuropathy, and active smoking were associated with increased levels of ECV. Active smoking exhibited the largest effect size (\u03b2 = 2.0 percentage points, 95% CI 0.7\u20133.3). Former smokers ECV similar to that of never smokers. Albuminuria and systolic blood pressure were inversely associated with ECV in multivariable analysis, but after adjustment for medication suspected to affect ECV, the association with albuminuria was no longer significant (P = 0.1). Sodium\u2013glucose cotransporter 2 inhibitor treatment was not significantly associated with reduced ECV (\u22120.8%, 95% CI \u22121.7 to 0.06, P = 0.067).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Patients with complications of diabetes have increased ECV, not seen in patients without complications. Ischemic heart disease, autonomic neuropathy, and active but not former smoking were highly associated with increased ECV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc22-0942","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T16:44:13Z","timestamp":1665420253000},"page":"3032-3039","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":14,"title":["Myocardial Extracellular Volume Expansion in Type 2 Diabetes Is Associated With Ischemic Heart Disease, Autonomic Neuropathy, and Active Smoking"],"prefix":"10.2337","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1448-8663","authenticated-orcid":false,"given":"Annemie Stege","family":"Bojer","sequence":"first","affiliation":[{"name":"1Department of Cardiology and Endocrinology, Slagelse Hospital, Slagelse, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8586-6203","authenticated-orcid":false,"given":"Martin Heyn","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"1Department of Cardiology and Endocrinology, Slagelse Hospital, Slagelse, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"G\u00e6de","sequence":"additional","affiliation":[{"name":"1Department of Cardiology and Endocrinology, Slagelse Hospital, Slagelse, Denmark"},{"name":"2Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Lav","family":"Madsen","sequence":"additional","affiliation":[{"name":"3Department of Cardiology, Copenhagen University Hospital Herlev-Gentofte, Herlev, Denmark"},{"name":"4Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"2022120119564574700_B1","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s00125-018-4700-5","article-title":"Excess risk of hospitalisation for heart failure among people with type 2 diabetes","volume":"61","author":"Rosengren","year":"2018","journal-title":"Diabetologia"},{"key":"2022120119564574700_B2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"2022120119564574700_B3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijcard.2016.07.083","article-title":"Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function","volume":"221","author":"J\u00f8rgensen","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022120119564574700_B4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ehjci\/jez266","article-title":"Cardiac perfusion, structure, and function in type 2 diabetes mellitus with and without diabetic complications","volume":"21","author":"S\u00f8rensen","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022120119564574700_B5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12933-020-01160-y","article-title":"Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes","volume":"19","author":"Bojer","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"2022120119564574700_B6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"2022120119564574700_B7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0140-6736(54)90924-1","article-title":"Diabetic angiopathy: a specific vascular disease","volume":"266","author":"Lundbaek","year":"1954","journal-title":"Lancet"},{"key":"2022120119564574700_B8","doi-asserted-by":"crossref","first-page":"H2109","DOI":"10.1152\/ajpheart.00157.2009","article-title":"Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes","volume":"297","author":"Ares-Carrasco","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022120119564574700_B9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/CIRCHEARTFAILURE.114.001963","article-title":"Smad3 signaling promotes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice","volume":"8","author":"Biernacka","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2022120119564574700_B10","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1093\/ehjci\/jeab220","article-title":"Multimodality imaging approach to left ventricular dysfunction in diabetes: an expert consensus document from the European Association of Cardiovascular Imaging","volume":"23","author":"Marwick","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022120119564574700_B11","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/jmri.25268","article-title":"Histological validation of cardiac magnetic resonance T1 mapping for detecting diffuse myocardial fibrosis in diabetic rabbits","volume":"44","author":"Zeng","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"2022120119564574700_B12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijcard.2020.07.013","article-title":"The combined effects of cardiac geometry, microcirculation, and tissue characteristics on cardiac systolic and diastolic function in subclinical diabetes mellitus-related cardiomyopathy","volume":"320","author":"Jiang","year":"2020","journal-title":"Int J Cardiol"},{"key":"2022120119564574700_B13","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"2022120119564574700_B14","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2337\/dc18-0324","article-title":"Poor glycemic control is associated with increased extracellular volume fraction in diabetes","volume":"41","author":"Al-Badri","year":"2018","journal-title":"Diabetes Care"},{"key":"2022120119564574700_B15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/eht193","article-title":"Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission","volume":"35","author":"Wong","year":"2014","journal-title":"Eur Heart J"},{"key":"2022120119564574700_B16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"2022120119564574700_B17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2337\/dc19-2172","article-title":"Reduced myocardial perfusion reserve in type 2 diabetes is caused by increased perfusion at rest and decreased maximal perfusion during stress","volume":"43","author":"S\u00f8rensen","year":"2020","journal-title":"Diabetes Care"},{"key":"2022120119564574700_B18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12933-020-01135-z","article-title":"Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics","volume":"19","author":"S\u00f8rensen","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"2022120119564574700_B19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022120119564574700_B20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjcard.2013.02.060","article-title":"Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus","volume":"112","author":"Rao","year":"2013","journal-title":"Am J Cardiol"},{"key":"2022120119564574700_B21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","article-title":"Cardiac fibrosis - a short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"2022120119564574700_B22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1207\/s15327906mbr2603_7","article-title":"How many subjects does it take to do a regression analysis","volume":"26","author":"Green","year":"1991","journal-title":"Multivariate Behav Res"},{"key":"2022120119564574700_B23","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/hrt.2005.087171","article-title":"Cigarette smoking induces atrial fibrosis in humans via nicotine","volume":"93","author":"Goette","year":"2007","journal-title":"Heart"},{"key":"2022120119564574700_B24","doi-asserted-by":"crossref","first-page":"18616","DOI":"10.1038\/s41598-019-54956-8","article-title":"Association of smoking and physical inactivity with MRI derived changes in cardiac function and structure in cardiovascular healthy subjects","volume":"9","author":"Schafnitzel","year":"2019","journal-title":"Sci Rep"},{"key":"2022120119564574700_B25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","article-title":"Diabetic autonomic neuropathy","volume":"26","author":"Vinik","year":"2003","journal-title":"Diabetes Care"},{"key":"2022120119564574700_B26","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1159\/000464125","article-title":"Anti-fibrosis effect of relaxin and spironolactone combined on isoprenaline-induced myocardial fibrosis in rats via inhibition of endothelial-mesenchymal transition","volume":"41","author":"Cai","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"2022120119564574700_B27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/ijpvm.IJPVM_322_16","article-title":"Effect of angiotensin-converting enzyme inhibitor on cardiac fibrosis and oxidative stress status in lipopolysaccharide-induced inflammation model in rats","volume":"8","author":"Abareshi","year":"2017","journal-title":"Int J Prev Med"},{"key":"2022120119564574700_B28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"2022120119564574700_B29","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.2337\/dc22-S010","article-title":"10. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes\u20142022","volume":"45","author":"Draznin","year":"2022","journal-title":"Diabetes Care"},{"key":"2022120119564574700_B30","doi-asserted-by":"crossref","first-page":"e005539","DOI":"10.1161\/JAHA.117.005539","article-title":"Diabetes mellitus, microalbuminuria, and subclinical cardiac disease: identification and monitoring of individuals at risk of heart failure","volume":"6","author":"Swoboda","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2022120119564574700_B31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1681\/ASN.2019111168","article-title":"Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: a secondary analysis of the CREDENCE randomized trial","volume":"31","author":"Jardine","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2022120119564574700_B32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"2022120119564574700_B33","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jcmg.2020.10.017","article-title":"Empagliflozin reduces myocardial extracellular volume in patients with type 2 diabetes and coronary artery disease","volume":"14","author":"Mason","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022120119564574700_B34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/db17-1496","article-title":"Metabolic syndrome is associated with impaired diastolic function independently of MRI-derived myocardial extracellular volume: the MESA study","volume":"67","author":"Ladeiras-Lopes","year":"2018","journal-title":"Diabetes"},{"key":"2022120119564574700_B35","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacc.2013.05.078","article-title":"Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"62","author":"Liu","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022120119564574700_B36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-017-0651-2","article-title":"Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain","volume":"17","author":"Cao","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2022120119564574700_B37","doi-asserted-by":"crossref","first-page":"9584278","DOI":"10.1155\/2017\/9584278","article-title":"Assessment of diabetic cardiomyopathy by cardiovascular magnetic resonance T1 mapping: correlation with left-ventricular diastolic dysfunction and diabetic duration","volume":"2017","author":"Shang","year":"2017","journal-title":"J Diabetes Res"},{"key":"2022120119564574700_B38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12872-021-02024-3","article-title":"Effects of empagliflozin in different phases of diabetes mellitus-related cardiomyopathy: a prospective observational study","volume":"21","author":"Oka","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2022120119564574700_B39","doi-asserted-by":"crossref","first-page":"e011000","DOI":"10.1161\/CIRCIMAGING.120.011000","article-title":"Examining the relationship and prognostic implication of diabetic status and extracellular matrix expansion by cardiac magnetic resonance","volume":"13","author":"Khan","year":"2020","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/12\/3032\/692817\/dc220942.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/12\/3032\/692817\/dc220942.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T15:05:40Z","timestamp":1669907140000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/45\/12\/3032\/147721\/Myocardial-Extracellular-Volume-Expansion-in-Type"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,10,10]]},"published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc22-0942","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}